Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
R&D Expense Growth
12.61%
Quarterly · Period ending:
TEVA R&D Expense Growth
Latest reported12.61%period ending
Latest reported12.61%period ending
TEVA Quarterly R&D Growth (QoQ) (0.00% → 12.61%)
Latest values, visible window
High-resolution chart · PNG
TEVA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 12.6126% | |
| -16.8539% | |
| 4.2969% | |
| 4.918% | |
| -1.2146% | |
| -8.8561% | |
| 12.9167% | |
| -10.7807% | |
| 11.157% | |
| 3.4188% | |
| -7.5099% | |
| -8% | |
| 8.6957% | |
| 20.4762% | |
| 20% | |
| -23.2456% | |
| 1.3333% | |
| -7.7869% | |
| 9.9099% | |
| -10.4839% | |
| -2.3622% | |
| -33.5079% | |
| 48.062% | |
| 14.6667% | |
| 1.81% | |
| -40.9091% | |
| 55.8333% | |
| -13.0435% | |
| 5.7471% | |
| -11.5254% | |
| -5.1447% | |
| 7.2414% | |
| -8.5174% | |
| -11.9444% | |
| -33.945% | |
| 12.1399% | |
| 6.3457% | |
| -33.1871% | |
| 3.1674% | |
| 76.8% | |
| -3.599% | |
| -12.7803% | |
| 23.5457% | |
| -6.4767% | |
| 16.2651% | |
| -12.4011% | |
| -8.0097% | |
| 19.7674% | |
| -2.5496% | |
| -14.1119% | |
| 18.1034% | |
| 2.6549% | |
| 3.0395% | |
| -25.5656% | |
| 36.4198% | |
| 8.7248% | |
| 2.0548% | |
| -24.3523% | |
| 70.0441% | |
| -6.5844% | |
| 1.6736% | |
| -11.4815% | |
| 12.9707% | |
| 10.1382% | |
| 2.8436% | |
| -3.653% | |
| 12.3077% | |
| 15.3846% | |
| -22.8311% | |
| -86.4564% | |
| 733.5052% | |
| -2.0202% | |
| 10.6145% | |
| 6.5476% | |
| 19.1489% | |
| 2.9197% | |
| 1.4815% | |
| -1.6752% | |
| 2.2338% | |
| 11.3599% | |
| 17.3152% | |
| 5.1125% | |
| 5.8442% | |
| 2.0994% | |
| 2.6077% | |
| -4.8544% | |
| 2.5442% | |
| 3.6697% | |
| 28.047% | |
| 6.7398% | |
| 16.4234% | |
| 12.9897% | |
| 4.5259% | |
| -11.619% | |
| 29.3103% | |
| 10.3261% | |
| 4.8433% | |
| 18.6893% | |
| 31.4356% | |
| -17.0293% |